You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myelosuppression

Showing 1 - 25 of 469
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GSTP1 and Other Gene Polymorphisms With Platinum-induced

Not yet recruiting
  • Non-small Cell Lung Cancer
  • GSTP1 A313G （AA）
  • (no location specified)
Nov 16, 2023

Hepatic Impairment and Myelosuppression in Breast Cancer

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 11, 2023

    Learn About Dangers Linked to Myelosuppression in Breast Cancer

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Jan 24, 2023

      Hematologic Tumors, Neutropenia, Anemia Trial in Wuhan (umbilical cord derived mesenchymal stem cells)

      Not yet recruiting
      • Hematologic Neoplasms
      • +5 more
      • umbilical cord derived mesenchymal stem cells
      • Wuhan, Hubei, China
      • +2 more
      Jan 3, 2023

      Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

      Active, not recruiting
      • Extensive-stage Small-cell Lung Cancer
      • Haikou, Hainan, China
        Hainan General Hospital
      Jun 13, 2022

      Neoadjuvant Chemoradiotherapy for Rectal Cancer

      Recruiting
      • Rectal Cancer Stage II
      • Rectal Cancer Stage III
      • MRI
      • blood routine test
      • Beijing, Beijing, China
        Peking University third hospital
      Jul 11, 2021

      Integrated Chinese Medicine With Western Medicine for Reduction

      Completed
      • Myelosuppression
      • Chemotherapy and Integrated Chinese Medicine With Western Medicine for cancer treatment
      • (no location specified)
      Jun 28, 2022

      Nasopharyngeal Carcinoma, Leucogen, Chemo Trial in Guangzhou (5-fu, Lobaplatin, Placebo)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • +3 more
      • Guangzhou, Guangdong, China
        Department of Radiation Oncology, Sun Yat-Sen University Cancer
      Mar 10, 2023

      Plasma Concentration of Linezolid Antibiotic and Treatment

      Recruiting
      • Myelosuppression
      • +2 more
        • Taipei, Test2, Taiwan
          National Taiwan University Hospital
        Feb 8, 2022

        Myelosuppression Adult, Chemotherapeutic Toxicity, Small Cell Lung Cancer Trial (Trilaciclib)

        Approved for marketing
        • Myelosuppression Adult
        • +2 more
        • (no location specified)
        Mar 17, 2021

        Cytomegalovirus Retinitis, HIV Trial (Foscarnet sodium)

        Withdrawn
        • Cytomegalovirus Retinitis
        • HIV Infections
        • Foscarnet sodium
        • (no location specified)
        Oct 27, 2021

        Cytomegalovirus Retinitis, HIV Trial in United States (Foscarnet sodium)

        Completed
        • Cytomegalovirus Retinitis
        • HIV Infections
        • Foscarnet sodium
        • Los Angeles, California
        • +10 more
        Oct 26, 2021

        Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

        Recruiting
        • Prevention of Chemotherapy-induced Myelosuppression
        • ALRN-6924
        • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
        • Tamarac, Florida
        • +14 more
        Jan 31, 2023

        A Multicenter Prospective Post-registration Study of

        Recruiting
        • Solid Tumor
        • +5 more
        • Moscow, Not Required, Russian Federation
        • +2 more
        May 31, 2021

        Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)

        Not yet recruiting
        • Pancreatic Cancer
        • Nanjing, Jiangsu, China
          The Affiliated Hospital of Nanjing University Medical School
        Nov 21, 2023

        Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma

        Recruiting
        • Lymphoma, T-cell, Peripheral
        • Lymphoma, T-cell, Cutaneous
        • Nagoya, Japan
        • +2 more
        Nov 24, 2022

        Cord Trial in Jinan (Intravenous infusion of cord blood mononuclear cells, application of granulocyte stimulating factor)

        Recruiting
        • Cord
        • Intravenous infusion of cord blood mononuclear cells
        • application of granulocyte stimulating factor
        • Jinan, Shandong, China
          Pediatrics, Qianfoshan Hospital
        Nov 25, 2022

        Quality of Life, Fatigue, Complementary Trial in Taiwan (PG2)

        Terminated
        • Quality of Life
        • +2 more
        • Changhua, Taiwan
        • +9 more
        Jun 13, 2022

        Lung Cancer, Small-cell Lung Cancer Trial in Lebanon (Trilaciclib, Lurbinectedin)

        Recruiting
        • Lung Cancer
        • Small-cell Lung Cancer
        • Lebanon, New Hampshire
          Dartmouth Hitchcock Medical Center
        Nov 9, 2022

        Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

        Not yet recruiting
        • Extensive-stage Small-cell Lung Cancer
        • (no location specified)
        May 22, 2023

        Colorectal Cancer Metastatic, Myelosuppression-Adult, Chemotherapeutic Toxicity Trial in Worldwide (Trilaciclib, Placebo)

        Active, not recruiting
        • Colorectal Cancer Metastatic
        • +2 more
        • Tucson, Arizona
        • +81 more
        Jan 3, 2023

        LUTATHERA Injection General Use Result Survey

        Recruiting
        • Somatostatin Receptor-positive Neuroendocrine Tumor
        • LUTATHERA
        • Kashiwa, Chiba, Japan
        • +6 more
        Apr 25, 2023

        Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)

        Recruiting
        • Refractory/Relapse Acute Myeloid Leukemia
        • Kunming, Yunnan, China
          Department of Hematology,920th Hospital of Joint Logistic Suppor
        Mar 28, 2023

        Chemo-Induced Myelosuppression Trial (Careseng 1370, Placebo)

        Withdrawn
        • Chemotherapy-Induced Myelosuppression
        • Careseng 1370
        • Placebo
        • (no location specified)
        Dec 13, 2018

        Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)

        Recruiting
        • Gastric Cancer
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Jul 27, 2023